IL10 and pemphigus vulgaris: Interestingly, successful treatment (i.e., complete remission) with Rituximab of the autoimmune disease pemphigus vulgaris is characterized by a higher number of IL-10 producing Breg post-treatment compared to cases with incomplete remission [96].